Holly Drugs Private Limited, a active private limited company, was established on 18 July 2007 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232CH2007PTC030879. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Manju Batra (Additional Director), Deepak Batra (Director). Past directors included Sahil Batra, Sandeep Batra. It holds ₹6.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 392, 2Nd Floor Sector 37D, Chandigarh, Chandigarh, 160036.
U24232CH2007PTC030879
030879
18 July 2007
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Holly Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Batra | Additional Director | 07 Oct 2024 | Current |
| Deepak Batra | Director | 18 Jul 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 31 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Holly Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.77% increase. The company also saw a substantial fall in profitability, with a 25.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Holly Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2013 | Indian Bank | ₹4.00 M | Open |
| 26 Nov 2007 | State Of India | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Holly Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Holly Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Holly Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Manju Batra was appointed as a Additional Director was appointed as a Additional Director on 07 Oct 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Holly Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Holly Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Progress on A charge with Indian Bank amounted to Rs. 4.00 M with Charge ID 10454303 was registered on 24 Aug 2013. was documented.
A charge with State Of India amounted to Rs. 2.50 M with Charge ID 10084974 was registered on 26 Nov 2007. was recorded as a recent event.
Deepak Batra was appointed as a Director was appointed as a Director on 18 Jul 2007 & has been associated with this company since 18 years 5 months . was recorded as a recent event.
The CIN of Holly Drugs Private Limited is U24232CH2007PTC030879.
Holly Drugs Private Limited is headquartered at Sco 392, 2Nd Floor Sector 37D, Chandigarh, Chandigarh, 160036.
Holly Drugs Private Limited was incorporated on 18 July 2007.
The current directors of Holly Drugs Private Limited are
The primary industry of Holly Drugs Private Limited is Trade.
Holly Drugs Private Limited is unlisted.
The authorized capital of Holly Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Holly Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX